Browsing Barts Cancer Institute by Author "Agarwal, N"
Now showing items 1-2 of 2
-
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Choueiri, TK; Escudier, B; Powles, T; Tannir, NM; Mainwaring, PN; Rini, BI; Hammers, HJ; Donskov, F; Roth, BJ; Peltola, K (2016-07) -
Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)
Harshman, L; Werner, L; Wong, YN; Yu, E; Alva, A; Crabb, S; Powles, T; Rosenberg, J; Baniel, J; Vaishampayan, U (2015-09)